statistiche ricercatore

Continente	#
NA - Nord America	1.341
EU - Europa	840
AS - Asia	755
SA - Sud America	61
AF - Africa	6
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	1
Totale	3.007

Nazione	#
US - Stati Uniti d'America	1.303
CN - Cina	362
IT - Italia	290
PL - Polonia	220
SG - Singapore	157
IN - India	73
GB - Regno Unito	58
DE - Germania	54
BR - Brasile	52
IE - Irlanda	47
SE - Svezia	44
HK - Hong Kong	42
UA - Ucraina	35
VN - Vietnam	33
CA - Canada	30
FR - Francia	19
MY - Malesia	16
IR - Iran	15
RU - Federazione Russa	15
NL - Olanda	12
ID - Indonesia	11
CH - Svizzera	9
ES - Italia	9
BE - Belgio	8
FI - Finlandia	8
IQ - Iraq	6
KR - Corea	6
MX - Messico	6
AR - Argentina	5
JP - Giappone	5
TR - Turchia	5
TW - Taiwan	5
BD - Bangladesh	4
KZ - Kazakistan	3
NO - Norvegia	3
SI - Slovenia	3
ZA - Sudafrica	3
BJ - Benin	2
CO - Colombia	2
EU - Europa	2
GR - Grecia	2
LB - Libano	2
LT - Lituania	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AT - Austria	1
AU - Australia	1
AZ - Azerbaigian	1
BW - Botswana	1
CL - Cile	1
DM - Dominica	1
IL - Israele	1
JO - Giordania	1
PH - Filippine	1
PT - Portogallo	1
SV - El Salvador	1
TH - Thailandia	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.007

Nome	#
Economic evaluation of platelet-rich-plasma versus hyaluronic acid for the treatment of knee osteoarthritis. Scenarios to 1 and 5 years	460
Public engagement and dialogic accounting through social media during COVID-19 crisis: a missed opportunity?	387
Knee OA management: A cost-effectiveness analysis of platelet-rich-plasma versus hyaluronic acid for the intra-articular treatment of knee OA in France	329
Measuring Change Over Time in Socio-economic Deprivation and Health in an Urban Context: The Case Study of Genoa	314
Factors influencing the use of the balanced scorecard: evidence from a regional context	274
Factors Influencing the Use of the Balanced Scorecard: Evidence from a Regional Context in Italy	273
Cost effectiveness and willingness to pay for an innovative regenerative therapy: the Plateket richh-plasma for the intrarticular tereatment of the knee osteoarthritis	247
Socioeconomic status and waiting times for health services: An international literature review and evidence from the Italian National Health System	237
ACCOUNTING ROLE AND RETHORIC OF RISK and VALUE FOR MONEY IN PPPs. A comparative analysis	155
Social media e pandemia come catalizzatori di public engagement. Un’analisi empirica del fenomeno nei comuni italiani	151
Economic evaluation of PRP treatment. Research, style and methods	118
The impact of external support on microbusinesses’ strategic renewal	102
Totale	3.047

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	340	0	0	0	0	0	51	23	33	38	74	80	41
2021/2022	452	44	50	43	48	45	12	11	11	18	37	68	65
2022/2023	379	21	56	12	38	47	96	5	26	49	4	19	6
2023/2024	310	13	15	7	15	26	69	19	15	22	12	26	71
2024/2025	377	22	19	23	55	26	14	49	22	56	13	58	20
2025/2026	537	91	67	51	138	157	33	0	0	0	0	0	0
Totale													3.047